Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37GM046622-17
Application #
2184115
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1979-04-01
Project End
1997-03-31
Budget Start
1995-04-01
Budget End
1997-03-31
Support Year
17
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
O'Shea, D; Kim, R B; Wilkinson, G R (1997) Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators. Br J Clin Pharmacol 43:99-103
Kinirons, M T; Lang, C C; He, H B et al. (1996) Triazolam pharmacokinetics and pharmacodynamics in Caucasians and Southern Asians: ethnicity and CYP3A activity. Br J Clin Pharmacol 41:69-72
Kim, R B; Wilkinson, G R (1996) CYP2E1 activity is not altered by influenza vaccination. Br J Clin Pharmacol 42:529-30
Tateishi, T; Graham, S G; Krivoruk, Y et al. (1995) Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test. Br J Clin Pharmacol 40:411-2
May, D G; Porter, J; Wilkinson, G R et al. (1994) Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population. Clin Pharmacol Ther 55:492-500
O'Shea, D; Davis, S N; Kim, R B et al. (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359-67
He, H; Edeki, T I; Wood, A J (1994) Determination of low plasma timolol concentrations following topical application of timolol eye drops in humans by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl 661:351-6
Kim, R B; O'Shea, D; Wilkinson, G R (1994) Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity. Pharmacogenetics 4:162-5
Zhou, H H; Shay, S D; Wood, A J (1993) Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians. Chin Med J (Engl) 106:898-902
Robin, D W; Lee, M; Hasan, S S et al. (1993) Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 54:630-7